BioSpace News Archive

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), today announced that Eric. A. Adams, President and CEO of InMed, will present at 2021 BIO Digital, the premier biotech conference.

Lysogene today announced dosing of the first patient, at Royal Manchester Children’s Hospital, part of Manchester University NHS Foundation Trust, in the global adaptative-design clinical trial with LYS-GM101.

Thomas Jefferson University Hospitals and Mentice have formed a strategic collaboration to establish a Simulation Center of Excellence uniting Jefferson’s world-class interventional radiology team with Mentice’s virtual patient technology aiming to elevate clinical training and to introduce advanced Virtual Reality simulation solutions for physicians in clinical practice.

Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference.

Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced the pricing of its underwritten public offering of 7,042,254 shares of its common stock at a price to the public of $17.75 per share.

LifeStance Health Group, Inc. (“LifeStance Health” or the “Company”), one of the nation’s largest providers of outpatient mental health care, today announced the pricing of its initial public offering of 40,000,000 shares of its common stock at a public offering price of $18.00 per share.

BioTheryX, Inc., today announced the dosing of the first patient in a dose escalation clinical trial of BTX-A51 in advanced solid tumor malignancies that are dependent upon MYC, one of the most commonly known oncogenic drivers

Provectus Algae, an Australian biotechnology company specialising in the optimisation of algae to produce high-value compounds for use in a wide array of industries and applications, appointed Mark Livings, co-founder and CEO of Lyre’s Non-Alcoholic Spirits and BrandLink Group, to its Advisory Board.

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Healthcare Conference on Thursday, June 10, 2021, at 5:30 PM ET.

The report highlights trends prevailing in the global biopsy devices market with the factors driving the market growth and those hampering it.